vs
Side-by-side financial comparison of ACTELIS NETWORKS INC (ASNS) and Bolt Biotherapeutics, Inc. (BOLT). Click either name above to swap in a different company.
Bolt Biotherapeutics, Inc. is the larger business by last-quarter revenue ($2.5M vs $1.4M, roughly 1.8× ACTELIS NETWORKS INC). ACTELIS NETWORKS INC runs the higher net margin — -184.5% vs -265.2%, a 80.8% gap on every dollar of revenue. Over the past eight quarters, ACTELIS NETWORKS INC's revenue compounded faster (37.2% CAGR vs -31.2%).
Actelis Networks Inc develops and manufactures high-performance broadband access networking solutions for telecom operators, enterprises and government entities. Its core products include Ethernet over copper systems delivering cost-effective high-speed connectivity over existing copper infrastructure, with key markets across North America, Europe and the Asia-Pacific.
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
ASNS vs BOLT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $2.5M |
| Net Profit | $-2.5M | $-6.6M |
| Gross Margin | 35.1% | — |
| Operating Margin | -122.3% | -283.4% |
| Net Margin | -184.5% | -265.2% |
| Revenue YoY | 28.6% | — |
| Net Profit YoY | -40.1% | 58.4% |
| EPS (diluted) | $-5.08 | $-9.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $2.5M | ||
| Q3 25 | $643.0K | $2.2M | ||
| Q2 25 | $941.0K | $1.8M | ||
| Q1 25 | $721.0K | $1.2M | ||
| Q4 24 | $1.1M | $0 | ||
| Q3 24 | $2.5M | $1.1M | ||
| Q2 24 | $3.4M | $1.3M | ||
| Q1 24 | $726.0K | $5.3M |
| Q4 25 | $-2.5M | $-6.6M | ||
| Q3 25 | $-2.0M | $-7.1M | ||
| Q2 25 | $-1.9M | $-8.6M | ||
| Q1 25 | $-1.9M | $-11.0M | ||
| Q4 24 | $-1.8M | $-15.9M | ||
| Q3 24 | $-511.0K | $-15.2M | ||
| Q2 24 | $-78.0K | $-21.2M | ||
| Q1 24 | $-2.0M | $-10.8M |
| Q4 25 | 35.1% | — | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 32.4% | — | ||
| Q1 25 | 34.8% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 68.6% | — | ||
| Q2 24 | 56.6% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | -122.3% | -283.4% | ||
| Q3 25 | -300.0% | -355.1% | ||
| Q2 25 | -188.4% | -510.5% | ||
| Q1 25 | -251.3% | -991.4% | ||
| Q4 24 | -154.0% | — | ||
| Q3 24 | -12.5% | -1441.1% | ||
| Q2 24 | 1.9% | -1772.3% | ||
| Q1 24 | -257.7% | -324.1% |
| Q4 25 | -184.5% | -265.2% | ||
| Q3 25 | -307.9% | -329.4% | ||
| Q2 25 | -202.0% | -474.6% | ||
| Q1 25 | -258.0% | -903.4% | ||
| Q4 24 | -169.4% | — | ||
| Q3 24 | -20.1% | -1330.1% | ||
| Q2 24 | -2.3% | -1662.4% | ||
| Q1 24 | -273.6% | -205.0% |
| Q4 25 | $-5.08 | $-9.38 | ||
| Q3 25 | $-0.17 | $-3.72 | ||
| Q2 25 | $-0.21 | $-4.46 | ||
| Q1 25 | $-0.22 | $-0.29 | ||
| Q4 24 | $-7.90 | $-13.73 | ||
| Q3 24 | $-0.09 | $-7.93 | ||
| Q2 24 | $-0.01 | $-11.12 | ||
| Q1 24 | $-0.50 | $-0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $27.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.8M | $26.5M |
| Total Assets | $9.5M | $56.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $27.5M | ||
| Q3 25 | $1.5M | $31.9M | ||
| Q2 25 | $393.0K | $34.8M | ||
| Q1 25 | $1.1M | $38.8M | ||
| Q4 24 | $2.0M | $47.3M | ||
| Q3 24 | $2.2M | $53.8M | ||
| Q2 24 | $2.4M | $73.7M | ||
| Q1 24 | $1.4M | $91.3M |
| Q4 25 | — | — | ||
| Q3 25 | $150.0K | — | ||
| Q2 25 | $150.0K | — | ||
| Q1 25 | $150.0K | — | ||
| Q4 24 | $150.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $148.0K | — |
| Q4 25 | $4.8M | $26.5M | ||
| Q3 25 | $3.0M | $32.1M | ||
| Q2 25 | $1.3M | $38.8M | ||
| Q1 25 | $2.6M | $46.8M | ||
| Q4 24 | $3.0M | $57.2M | ||
| Q3 24 | $3.1M | $72.0M | ||
| Q2 24 | $1.1M | $85.9M | ||
| Q1 24 | $-1.7M | $104.2M |
| Q4 25 | $9.5M | $56.7M | ||
| Q3 25 | $6.9M | $65.1M | ||
| Q2 25 | $6.0M | $75.5M | ||
| Q1 25 | $7.1M | $85.9M | ||
| Q4 24 | $8.2M | $99.6M | ||
| Q3 24 | $8.8M | $109.3M | ||
| Q2 24 | $8.4M | $124.2M | ||
| Q1 24 | $10.5M | $142.9M |
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-7.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-7.2M | ||
| Q3 25 | $-2.4M | $-9.7M | ||
| Q2 25 | $-1.0M | $-9.6M | ||
| Q1 25 | $-2.2M | $-13.4M | ||
| Q4 24 | $-1.8M | $-14.4M | ||
| Q3 24 | $-2.4M | $-14.0M | ||
| Q2 24 | $-2.1M | $-16.1M | ||
| Q1 24 | $-203.0K | $-16.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | $-204.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1227.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | -28.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 3.6% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASNS
| Europe Middle East And Africa | $1.1M | 83% |
| Other | $228.0K | 17% |
BOLT
Segment breakdown not available.
